Community spread of multiple infectious diseases in Cambodia from a One Health perspective

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

RACSMEI is a nationwide One Health, multi-pathogen effort using a nationally representative population survey combined with animal and environmental sampling. The project pairs social-science interviews with multiplex laboratory diagnostics to test for 57 priority pathogens and builds a structured biobank and curated datasets. Mathematical modeling and integrated analysis will link burden, ecology, transmission patterns, and population immunity to inform public-health decisions. The program also includes capacity building and stakeholder engagement to strengthen national institutions and promote uptake of results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Residency in the village for more than 6 months;
* Age between 2 and 75 years old at the time of inclusion;
* For adults: provision of written consent;
* For children aged 2-17 years: written parental consent form, verbal assent from children aged 13-17 years;

Exclusion Criteria:

* Unable to understand or consent;
* Under guardianship or deprived of liberty;
* Medical conditions that impede survey participation;
* Refusal to participate in the study.

Where it's running

• Institut Pasteur du Cambodge
  Phnom Penh, Phnom Penh, Cambodia Recruiting

Study contacts

• Principal investigator: Claude Flamand, Ph.D. — Institut Pasteur du Cambodge
• Study coordinator: Claude Flamand, Ph.D.
• Email: cflamand@pasteur-kh.org
• Phone: +855012333650

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Diphtheria, Tetanus, Pertussis, and Poliovirus Vaccine Trial in Young Children

  This is a small early-phase study testing a diphtheria, tetanus, pertussis and polio vaccine formulation in children from 2 months to 6 years to see if it is safe and can provoke an immune response.

  Recruiting Phase 1/2 Institute of Medical Biology, Chinese Academy of Medical Sciences · Chongqing, Chongqing Municipality and 2 other locations · NCT07891104

• Expanding Access to Preventive Chemotherapy for Mobile and Migrant Communities

  This project tests whether a modified mass drug administration approach can reach mobile and migrant groups in Nigeria to reduce infections from river blindness, schistosomiasis, intestinal worms, and lymphatic filariasis.

  Recruiting Akwa Ibom State University, Ikot Akpaden, Nigeria · Ondo, Ondo, Taraba and Akwa Ibom · NCT07707817

• R-MVST cell therapy for viral infections in children and young adults

  This will try giving rapidly generated virus-specific T cells (R-MVST) to children and young adults whose weakened immune systems have recurrent or treatment-resistant infections with EBV, CMV, adenovirus, or BK virus.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06926894

• Using donor T-cells to treat viral infections after stem cell transplantation

  This study is testing if special immune cells from related donors can help patients who had a stem cell transplant fight off viral infections like CMV and ADV.

  Recruiting Phase 2 St. Jude Children's Research Hospital · Memphis, Tennessee · NCT05664126

• Donor-derived virus-specific T cell therapy for CMV or adenovirus after organ or stem-cell transplant

  This tests donor-derived virus-specific T cells to treat CMV or adenovirus reactivation in people who have had a solid organ or stem-cell transplant.

  Recruiting Early Phase 1 Ohio State University Comprehensive Cancer Center · Columbus, Ohio and 1 other locations · NCT03665675

• Tick-borne infections in Finland: a broad, multicenter look at Lyme, TBE and other infections

  This study tests how common and how these infections show up in people with suspected tick-borne disease in Finland.

  Recruiting at 2 sites Turku University Hospital · Helsinki and 2 other locations · NCT07897825

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.